Aveanna Healthcare stock falls after J.H. Whitney announces secondary offering

Published 21/10/2025, 22:20
© Reuters.

Investing.com -- Aveanna Healthcare Holdings Inc (NASDAQ:AVAH) stock dropped 8.2% in after-hours trading Tuesday following an announcement that major shareholder J.H. Whitney Equity Partners will sell 10 million shares in a secondary offering.

The home healthcare provider disclosed that certain selling stockholders affiliated with J.H. Whitney Equity Partners VII, LLC have commenced the secondary offering, with an additional option for underwriters to purchase up to 1.5 million more shares within 30 days. Aveanna will not receive any proceeds from the sale as the company itself is not offering any shares.

Jefferies LLC and J.P. Morgan Securities LLC are serving as joint lead book-running managers for the offering, with Barclays and RBC Capital Markets acting as additional bookrunners.

Aveanna Healthcare, headquartered in Atlanta, operates across 38 states providing pediatric and adult healthcare services. The company’s service portfolio includes nursing, rehabilitation, occupational nursing in schools, therapy services, and day treatment centers for medically fragile patients. Aveanna also offers home health and hospice services, enteral nutrition delivery, case management, and respite healthcare services.

The stock’s decline reflects typical market reaction to large secondary offerings, which can create downward pressure on share prices due to increased supply.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.